CDC Emerging Infections · Jul 13, 2026
Rapid Expansion of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Genotype D1.1 Virus across Flyway Regions, North America, Fall 2024
M. Scotch et al.
Latest medical news · page 79
The latest headlines across every section, pulled from official and open-access sources.
CDC Emerging Infections · Jul 13, 2026
Hepatitis A Outbreak in Skilled Nursing Facility, Los Angeles County, California, USA, 2025
M. T. Yazdi et al.
CDC Emerging Infections · Jul 13, 2026
Detection of Dengue Virus in Aedes aegypti Mosquitoes, Dubai, United Arab Emirates
N. Nowotny et al.
CDC Emerging Infections · Jul 13, 2026
Human Cases of Borrelia miyamotoi Disease, Slovenia, 2025
P. Bogovič et al.
FDA MedWatch · Jul 13, 2026
Pulmonary Valve Catheter Delivery System Recall: Medtronic Removes Harmony Delivery Catheter System (DCS)
The distal tip in certain lots of the Medtronic Harmony Delivery Catheter System (DCS) may detach which can require endovascular retrieval or surgical intervention.
MedCity News · Jul 13, 2026
Former Mayo Clinic Leader Sues System Over Alleged AI Cover-Up: 6 Things to Know
A former Mayo Clinic research director claims she was silenced, demoted and ultimately fired for sounding the alarm on AI safety and patient privacy lapses at the health system. Traci Tamiko Eto is now suing Mayo for retaliation. The post Former Mayo Clinic Leader Sues System Over Alleged AI Cover-Up: 6 Things to Know appeared first on MedCity News .
MedCity News · Jul 13, 2026
Does CMS Know What It Is Doing With Its GLP-1 Obesity Coverage Pilot?
CMS’s new GLP-1 Bridge program expands Medicare access to obesity drugs but raises concerns about cost, supply and implementation challenges. The post Does CMS Know What It Is Doing With Its GLP-1 Obesity Coverage Pilot? appeared first on MedCity News .
JAMA Network Open · Jul 13, 2026
Age, Multidomain Lifestyle Intervention, and White Matter Integrity
This prespecified secondary analysis of a randomized clinical trial assesses whether a multidomain lifestyle intervention, vs a self-guided program, alters trajectories of cerebrovascular magnetic resonance imaging (MRI) markers, whether baseline diffusion MRI estimates subsequent vascular injury, and whether any effects differ by age among adults 60 to 79 years of age who are at increased risk for cognitive decline.
JAMA Network Open · Jul 13, 2026
Structure–Informed Measures of Transition Success for Youth With Sickle Cell
Hematology
JAMA Network Open · Jul 13, 2026
Equity in Population-Wide Genomic Screening
Genetics and Genomics
JAMA Network Open · Jul 13, 2026
Geographic and Social Equity in Population-Wide Genomic Screening
This cross-sectional study reports on the implementation of a population-wide genomic screening program in South Carolina and assesses rates of screening for genetic disorders and positivity prevalence by rurality and social disadvantage.
JAMA Network Open · Jul 13, 2026
Coping Strategies for Transition Readiness Among Youth With Sickle Cell Disease
This cross-sectional study explores whether coping strategies and social support are associated with readiness to transition to adult health care in young adults with sickle cell disease.
JAMA Network Open · Jul 13, 2026
Neonatal Outcomes Following SSRI Use During Pregnancy
This cohort study uses a target trial emulation approach to evaluate neonatal outcomes for pregnancies with continuation of selective serotonin reuptake inhibitors (SSRIs) vs discontinuation.
JAMA Network Open · Jul 13, 2026
Medically Assisted Reproduction and Hormone-Related Cancers
This cohort study uses an emulated target trial design to evaluate the risk of hormone-related cancers after medically assisted reproductive treatment.
JAMA Network Open · Jul 13, 2026
Plasma Phosphorylated Tau 217 in Participants at Risk for CTE
This case-control study evaluates the clinical utility of plasma phosphorylated tau 217 measures for identifying neuropathology among individuals at risk for chronic traumatic encephalopathy (CTE).
JAMA Network Open · Jul 13, 2026
Vision Loss–Related Conditions in American Indian or Alaska Native Children
This cross-sectional study measures annual rates of vision screening at well-child care visits and the prevalence of vision loss–related conditions among American Indian or Alaska Native children in Minnesota.
JAMA Network Open · Jul 13, 2026
Children’s Birthday Gatherings and SARS-CoV-2 Infection in Grandparents
This cohort study uses Danish registry data to examine the association of grandchild birthdays, as a proxy for opportunity for social gathering, with SARS-CoV-2 infection in grandparents.
JAMA Network Open · Jul 13, 2026
Tenecteplase vs Alteplase and Time to Treatment for Acute Ischemic Stroke
This cohort study compares door-to-needle and door-in-door-out times between tenecteplase-treated and alteplase-treated patients with acute ischemic stroke in US hospitals.
NHS England · Jul 12, 2026
Young people urged to book lifesaving meningitis jab at high street pharmacies
Hundreds of thousands of students heading to university this autumn are being urged by the NHS to book a potentially lifesaving MenB vaccine from today before term starts. Appointments to get the jab can now be booked at high street pharmacies across England, offering vital protection for 17 and 18-year-olds currently in the last year […]
MedCity News · Jul 12, 2026
AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug
AstraZeneca is getting rights to a Sino Biopharmaceutical drug that offers a dual mechanism to treat chronic obstructive pulmonary disease, or COPD. It’s the same approach as an FDA-approved drug that Merck acquired last year in a multi-billion dollar deal. The post AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug appeared first on MedCity News .
MedCity News · Jul 12, 2026
Prior Authorization is a Fight and AI Won’t End It — Stop Pretending Otherwise
The honest question is not whether AI will end the fight. It will not. The honest question is what AI does to a fight that has been structurally imbalanced for 30 years. The post Prior Authorization is a Fight and AI Won’t End It — Stop Pretending Otherwise appeared first on MedCity News .
MedCity News · Jul 12, 2026
Medicaid’s Next Performance Test: Can Plans Reach the Members They’re Accountable For?
For many of Medicaid’s highest-need members, the problem isn’t that services don’t exist. It’s that the system can’t consistently reach the people who need those services most. The post Medicaid’s Next Performance Test: Can Plans Reach the Members They’re Accountable For? appeared first on MedCity News .
MedCity News · Jul 12, 2026
Stop the Revolving Door: Why Five-Year Contracts are the Key to Saving Medicare Advantage
To truly deliver on the promise of proactive, preventive care for seniors with complex, chronic conditions, we should move away from the current one-year open enrollment cycle and toward a five-year contract period. The post Stop the Revolving Door: Why Five-Year Contracts are the Key to Saving Medicare Advantage appeared first on MedCity News .
Fierce Biotech · Jul 12, 2026
Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA's desk
Apnimed is having sweet dreams of an IPO that could fund the planned commercial launch of an obstructive sleep apnea therapy that is currently awaiting an FDA approval decision.